Becton, Dickinson uses rating-sensitive bridge for Bard takeover

Becton, Dickinson and Co, the US medical devices group, has obtained a $15.7bn bridge loan for its $24bn buyout of CR Bard, a rival in the same industry. The margin will depend on whether BD can hold on to its credit ratings.